Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

FDA approves amendments to ARISE study of AGI-1067

Feb. 24, 2005

Enrollment completed in ATLAS study of Taxus Liberte stent

Feb. 24, 2005

Japan Science and Technology develops fusion protein for atherosclerosis and cancer

Feb. 22, 2005

Therapeutic benefits of oxypurinol in congestive heart failure

Feb. 22, 2005

Aventis reports new NHE-1 inhibitors for angina pectoris and related disorders

Feb. 21, 2005

Aceon sNDA accepted for filing with priority review

Feb. 18, 2005

Orphan drug designation for INO-1001

Feb. 17, 2005

CTI-01 enters phase II study

Feb. 17, 2005

Topline data from STRIDE-2 study in PAH

Feb. 16, 2005

Beth Israel claims imatinib mesylate/rapamycin combination for vascular stenosis and restenosis

Feb. 11, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...